This inventor holds 1 USPTO granted patent. Top assignee: Solvo Biotechnology. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Balázs Sarkadi: Innovator in Multi-Drug Resistance Evaluation
Introduction
Balázs Sarkadi is a prominent inventor based in Budapest, Hungary. He has made significant contributions to the field of biotechnology, particularly in the evaluation of multi-drug resistance in cells. His innovative work has led to the development of a patented assay and reagent kit that aids in understanding drug resistance mechanisms.
Latest Patents
Sarkadi holds a patent for an "Assay and reagent kit for evaluation of multi-drug resistance in cells." This invention discloses methods and reagent kits for the quantitative in vitro determination of the functional status of multi-drug resistance in cells. The method is based on measuring the accumulation rate of free calcein within the cells after exposure to a cell-permeable form of calcein, which is a substrate for MDR proteins. This innovative approach allows for rapid screening of potential modulators of multi-drug resistant transport activity.
Career Highlights
Balázs Sarkadi is associated with Solvo Biotechnology, where he continues to advance research in drug resistance. His work has been instrumental in developing tools that facilitate the clinical screening of potential inhibitors of multi-drug resistance. With 1 patent to his name, Sarkadi's contributions are recognized in the scientific community.
Collaborations
Sarkadi has collaborated with notable colleagues, including Zsolt Holló and László Homolya. Their combined expertise has furthered research in the field of drug resistance and biotechnology.
Conclusion
Balázs Sarkadi's innovative work in the evaluation of multi-drug resistance has made a significant impact in biotechnology. His patented methods and collaborations highlight his commitment to advancing scientific research and improving clinical outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile